Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study-Reference-Cited by-同舟云学术

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

Published:2007-07 Issue:7 Volume:8 Page:595-602
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Grosso Federica,Jones Robin L,Demetri George D,Judson Ian R,Blay Jean-Yves,Le Cesne Axel,Sanfilippo Roberta,Casieri Paola,Collini Paola,Dileo Palma,Spreafico Carlo,Stacchiotti Silvia,Tamborini Elena,Tercero Juan Carlos,Jimeno Josè,D'Incalci Maurizio,Gronchi Alessandro,Fletcher Jonathan A,Pilotti Silvana,Casali Paolo G

Publisher

Elsevier BV

Subject

Oncology

Reference31 articles.

1. Soft tissue sarcoma;Brennan,2001

2. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group;Santoro;J Clin Oncol,1995

3. In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients;Izbicka;Ann Oncol,1998

4. Phase I and pharmacokinetic study of ecteinascidin-743, a new marine compound, administered as a 24-hour continuous inFusion in patients with solid tumors;Taamma;J Clin Oncol,2001

Cited by 406 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Late-Arriving but Welcome Advance in Sarcoma Therapy;New England Journal of Medicine;2024-09-05

2. Molecular characteristics and systemic treatment options of liposarcoma: A systematic review;Biomedicine & Pharmacotherapy;2024-09

3. Targeting MCM2 activates cancer-associated fibroblasts-like phenotype and affects chemo-resistance of liposarcoma cells against doxorubicin;Anti-Cancer Drugs;2024-08-07

4. Progress in histology specific treatments in soft tissue sarcoma;Expert Review of Anticancer Therapy;2024-08-05

5. Desmoplastic small round cell tumor: from genomics to targets, potential paths to future therapeutics;Frontiers in Cell and Developmental Biology;2024-07-30